bg6b

About a&r

analyze & realize is a leading Clinical Research Organisation (CRO) and Consultancy firm, specialised in the natural products and phytomedicines sectors.

In addition, our support extends from regulatory affairs matters right through to market entry, in order to achieve maximum success for our national and international clients.

bg4

Consulting

During the last decades, the demand for natural raw materials as a basis for safe and customer-friendly health products has risen considerably.

The growing trend towards a sustainable life style with a special focus on health contributes to increased sales of functional foods, food supplements, and other health products.

bg21

Clinical Research

analyze & realize GmbH as a Contract Research Organization (CRO) has long-standing experience in designing, planning, implementation, evaluation and publication of clinical trials to obtain/extend the product approval or optimize product marketing.

bg

Clinical Trials

Our Study Team has a longtime experience in running multicentric clinical trials. We have conducted over 200 Studies in Phase II – IV, including AMG- (national drug law), MPG- (medical device law), pilot and non-interventional Studies.

News and upcoming events

If you like, please meet us at the following events:
Vitafoods Asia 2016

1-2 September 2016, Hong Kong, China

Vitafoods Asia 2016

 

 

5th Supplement Claims Workshop
30 September 2016, Bussels, Belgium

Supply Side West
4-8 October, Las Vegas, USA

SupplySide West

5th Hightech Transfertag
11 October, Potsdam, Germany

HI Europe
29 November – 1 December, Frankfurt, Germany

Health Ingredients Europe

  • Banner NL#5

a&r News Digest – August 2016 Edition

We dedicate this month’s issue to Asia.

August 5 2016 – Tax relief for French customers

The French Ministère de l’Education Nationale de l’Enseignement Supérieur et de la Recherche confirmed that French clients for R&D services rendered by a&r are eligible for tax relief.

Das Ministère de l’Education Nationale de l’Enseignement Supérieur […]